药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Levorphanol
Eribulin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Eribulin.
Levorphanol
Bupranolol
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Bupranolol.
Levorphanol
Geranylgeranyl diphosphate
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Geranylgeranyl diphosphate.
Levorphanol
Farnesyl diphosphate
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Farnesyl diphosphate.
Levorphanol
Triptorelin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Triptorelin.
Levorphanol
Histrelin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Histrelin.
Levorphanol
Buserelin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Buserelin.
Levorphanol
Degarelix
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Degarelix.
Levorphanol
Mepyramine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Mepyramine.
Levorphanol
Pasireotide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pasireotide.
Levorphanol
Cariporide
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Cariporide.
Levorphanol
Amisulpride
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Amisulpride.
Levorphanol
Vernakalant
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vernakalant.
Levorphanol
Tandutinib
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Tandutinib.
Levorphanol
Ezogabine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Ezogabine.
Levorphanol
Farnesyl thiopyrophosphate
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Farnesyl thiopyrophosphate.
Levorphanol
Fleroxacin
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Fleroxacin.
Levorphanol
Vorinostat
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Vorinostat.
Levorphanol
Thiothixene
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Thiothixene.
Levorphanol
Pheniramine
The risk or severity of QTc prolongation can be increased when Lapatinib is combined with Pheniramine.